Gliomagenesis following chronic subdural hematoma: A case report
- Authors:
- Wei Wei
- Tao Yang
- Xingyou Liu
- Li Li
- Yongping Fan
-
Affiliations: Department of Traditional Chinese Medicine, Combined Research Institution for Encephalopathy of Chinese and Western Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, P.R. China - Published online on: May 16, 2025 https://doi.org/10.3892/etm.2025.12889
- Article Number: 139
This article is mentioned in:
Abstract
 |
 |
 |
|
Almenawer SA, Farrokhyar F, Hong C, Alhazzani W, Manoranjan B, Yarascavitch B, Arjmand P, Baronia B, Reddy K, Murty N and Singh S: Chronic subdural hematoma management: A systematic review and meta-analysis of 34,829 patients. Ann Surg. 259:449–457. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Bartek J Jr, Sjåvik K, Dhawan S, Sagberg LM, Kristiansson H, Ståhl F, Förander P, Chen CC and Jakola AS: Clinical course in chronic subdural hematoma patients aged 18-49 compared to patients 50 years and above: A multicenter study and meta-analysis. Front Neurol. 10(311)2019.PubMed/NCBI View Article : Google Scholar | |
|
Ducruet AF, Grobelny BT, Zacharia BE, Hickman ZL, DeRosa PL, Andersen KN, Sussman E, Carpenter A and Connolly ES Jr: The surgical management of chronic subdural hematoma. Neurosurg Rev. 35:155–169. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Henry J, Amoo M, Kissner M, Deane T, Zilani G, Crockett MT and Javadpour M: Management of chronic subdural hematoma: A systematic review and component network meta-analysis of 455 studies with 103 645 cases. Neurosurgery. 91:842–855. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, et al: The 2021 WHO classification of tumors of the central nervous system: A summary. Neuro Oncol. 23:1231–1251. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C and Barnholtz-Sloan JS: CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2016-2020. Neuro Oncol. 25 (12 Suppl 2):iv1–iv99. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Weller M, Wen PY, Chang SM, Dirven L, Lim M, Monje M and Reifenberger G: Glioma. Nat Rev Dis Primers. 10(33)2024.PubMed/NCBI View Article : Google Scholar | |
|
Tan AC, Ashley DM, López GY, Malinzak M, Friedman HS and Khasraw M: Management of glioblastoma: State of the art and future directions. CA Cancer J Clin. 70:299–312. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Yang W and Huang J: Chronic subdural hematoma: Epidemiology and natural history. Neurosurg Clin N Am. 28:205–210. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Kotwica Z and Zawirski M: Subdural hematoma caused by cerebral tumors. Zentralbl Neurochir. 47:259–262. 1986.PubMed/NCBI | |
|
Coombs JB, Coombs BL and Chin EJ: Acute spontaneous subdural hematoma in a middle-aged adult: Case report and review of the literature. J Emerg Med. 47:e63–e68. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Pavlov V, Bernard G and Chibbaro S: Chronic subdural haematoma management: An iatrogenic complication. Case report and literature review. BMJ Case Rep. 2012(bcr1220115397)2012.PubMed/NCBI View Article : Google Scholar | |
|
Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, et al: IDH1 and IDH2 mutations in gliomas. N Engl J Med. 360:765–773. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Picca A, Berzero G, Di Stefano AL and Sanson M: The clinical use of IDH1 and IDH2 mutations in gliomas. Expert Rev Mol Diagn. 18:1041–1051. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Ohgaki H and Kleihues P: The definition of primary and secondary glioblastoma. Clin Cancer Res. 19:764–772. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Colman H, Zhang L, Sulman EP, McDonald JM, Shooshtari NL, Rivera A, Popoff S, Nutt CL, Louis DN, Cairncross JG, et al: A multigene predictor of outcome in glioblastoma. Neuro Oncol. 12:49–57. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Levine AJ and Oren M: The first 30 years of p53: Growing ever more complex. Nat Rev Cancer. 9:749–758. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Tan PH, Ellis I, Allison K, Brogi E, Fox SB, Lakhani S, Lazar AJ, Morris EA, Sahin A, Salgado R, et al: The 2019 World Health Organization classification of tumours of the breast. Histopathology. 77:181–185. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Olivier M, Hollstein M and Hainaut P: TP53 mutations in human cancers: Origins, consequences, and clinical use. Cold Spring Harb Perspect Biol. 2(a001008)2010.PubMed/NCBI View Article : Google Scholar | |
|
Watanabe K, Tachibana O, Sata K, Yonekawa Y, Kleihues P and Ohgaki H: Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol. 6:217–223. 1996.PubMed/NCBI View Article : Google Scholar | |
|
Cancer Genome Atlas Research Network. Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, et al: Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med. 372:2481–2498. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P and Ellison DW: The 2016 World Health organization classification of tumors of the central nervous system: A summary. Acta Neuropathol. 131:803–820. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Wiestler B, Capper D, Holland-Letz T, Korshunov A, von Deimling A, Pfister SM, Platten M, Weller M and Wick W: ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis. Acta Neuropathol. 126:443–451. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Gilbert MR, Dignam JJ, Armstrong TS, Wefel JS, Blumenthal DT, Vogelbaum MA, Colman H, Chakravarti A, Pugh S, Won M, et al: A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med. 370:699–708. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Dummer R, Lebbé C, Atkinson V, Mandalà M, Nathan PD, Arance A, Richtig E, Yamazaki N, Robert C, Schadendorf D, et al: Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: Safety run-in and biomarker cohorts of COMBI-i. Nat Med. 26:1557–1563. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Stupp R, Taillibert S, Kanner A, Read W, Steinberg D, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS, Fink K, et al: Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: A randomized clinical trial. JAMA. 318:2306–2316. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Miao H, Choi BD, Suryadevara CM, Sanchez-Perez L, Yang S, De Leon G, Sayour EJ, McLendon R, Herndon JE II, Healy P, et al: EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma. PLoS One. 9(e94281)2014.PubMed/NCBI View Article : Google Scholar | |
|
Azimi P, Yazdanian T and Ahmadiani A: mRNA markers for survival prediction in glioblastoma multiforme patients: A systematic review with bioinformatic analyses. BMC Cancer. 24(612)2024.PubMed/NCBI View Article : Google Scholar | |
|
Rauhala M, Helén P, Huhtala H, Heikkilä P, Iverson GL, Niskakangas T, Öhman J and Luoto TM: Chronic subdural hematoma-incidence, complications, and financial impact. Acta Neurochir (Wien). 162:2033–2043. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Iihara K, Saito N, Suzuki M, Date I, Fujii Y, Houkin K, Inoue T, Iwama T, Kawamata T, Kim P, et al: The Japan neurosurgical database: Statistics update 2018 and 2019. Neurol Med Chir (Tokyo). 61:675–710. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Chen X, Huang W, Sun A, Wang L, Mo F and Guo W: Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: A meta-analysis. Thromb J. 19(69)2021.PubMed/NCBI View Article : Google Scholar | |
|
Edlmann E, Giorgi-Coll S, Whitfield PC, Carpenter K and Hutchinson PJ: Pathophysiology of chronic subdural haematoma: Inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation. 14(108)2017.PubMed/NCBI View Article : Google Scholar | |
|
Jiang R, Wang NP, Tanaka KA, Levy JH, Guyton RA, Zhao ZQ and Vinten-Johansen J: Factor Xa induces tissue factor expression in endothelial cells by P44/42 MAPK and NF-κB-dependent pathways. J Surg Res. 169:319–327. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Entezami P, Boulos A, Paul A, Nourollahzadeh E and Dalfino J: Contrast enhancement of chronic subdural hematomas after embolization of the middle meningeal artery. Interv Neuroradiol. 25:596–600. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Nordström CH: Letter to the editor: Rapid selective brain cooling with PolarCap(®)-A commercial delusion. J Neurotrauma. 40:1257–1258. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Lepić M and Sato H: Editorial: Chronic subdural hematoma (CSDH)-a well-known unknown. Front Neurol. 15(1461117)2024.PubMed/NCBI View Article : Google Scholar | |
|
Jensen T, Olsen MH, Christoffersen C, Binderup T and Fugleholm K: The cellular composition of chronic subdural hematoma. Acta Neurochir (Wien). 166(208)2024.PubMed/NCBI View Article : Google Scholar | |
|
Isaji T, Osuka K, Ohmichi Y, Ohmichi M, Naito M, Nakano T, Iwami K and Miyachi S: Expression of angiopoietins and angiogenic signaling pathway molecules in chronic subdural hematomas. J Neurotrauma. 37:2493–2498. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Semenza GL and Wang GL: A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol. 12:5447–5454. 1992.PubMed/NCBI View Article : Google Scholar | |
|
Patel SA, Nilsson MB, Le X, Cascone T, Jain RK and Heymach JV: Molecular mechanisms and future implications of VEGF/VEGFR in cancer therapy. Clin Cancer Res. 29:30–39. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Shen J, Zhang Y and Wu X: Rapamycin promotes hematoma resorption and enhances endothelial cell function by suppressing the mTOR/STAT3 signaling in chronic subdural hematoma. Exp Cell Res. 433(113829)2023.PubMed/NCBI View Article : Google Scholar | |
|
Suzuki M, Endo S, Inada K, Kudo A, Kitakami A, Kuroda K and Ogawa A: Inflammatory cytokines locally elevated in chronic subdural haematoma. Acta Neurochir (Wien). 140:51–55. 1998.PubMed/NCBI View Article : Google Scholar | |
|
Su GJ, Gao J, Wu CW, Zou JF, Zhang D, Zhu DL, Liu J, Zhang JH and Huang XJ: Serum levels of MMP-8 and MMP-9 as markers in chronic subdural hematoma. J Clin Med. 11(902)2022.PubMed/NCBI View Article : Google Scholar | |
|
Galvão RP and Zong H: Inflammation and gliomagenesis: Bi-Directional communication at early and late stages of tumor progression. Curr Pathobiol Rep. 1:19–28. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Bhat K, Balasubramaniyan V, Vaillant B, Ezhilarasan R, Hummelink K, Hollingsworth F, Wani K, Heathcock L, James JD, Goodman LD, et al: Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma. Cancer Cell. 24:331–346. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Yu H, Lee H, Herrmann A, Buettner R and Jove R: Revisiting STAT3 signalling in cancer: New and unexpected biological functions. Nat Rev Cancer. 14:736–746. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Katz AM, Amankulor NM, Pitter K, Helmy K, Squatrito M and Holland EC: Astrocyte-specific expression patterns associated with the PDGF-induced glioma microenvironment. PLoS One. 7(e32453)2012.PubMed/NCBI View Article : Google Scholar | |
|
Mega A, Nilsen MH, Leiss LW, Tobin NP, Miletic H, Sleire L, Strell C, Nelander S, Krona C, Hägerstrand D, et al: Astrocytes enhance glioblastoma growth. Glia. 68:316–327. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Pripp AH and Stanišić M: The correlation between pro- and anti-inflammatory cytokines in chronic subdural hematoma patients assessed with factor analysis. PLoS One. 9(e90149)2014.PubMed/NCBI View Article : Google Scholar | |
|
Hyvärinen T, Hagman S, Ristola M, Sukki L, Veijula K, Kreutzer J, Kallio P and Narkilahti S: Co-stimulation with IL-1β and TNF-α induces an inflammatory reactive astrocyte phenotype with neurosupportive characteristics in a human pluripotent stem cell model system. Sci Rep. 9(16944)2019.PubMed/NCBI View Article : Google Scholar | |
|
Raica M and Cimpean AM: Platelet-Derived growth factor (PDGF)/PDGF receptors (PDGFR) axis as target for antitumor and antiangiogenic therapy. Pharmaceuticals (Basel). 3:572–599. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Chaudhary PK and Kim S and Kim S: An insight into recent advances on platelet function in health and disease. Int J Mol Sci. 23(6022)2022.PubMed/NCBI View Article : Google Scholar | |
|
Xu X, Wang D, Han Z, Wang B, Gao W, Fan Y, Li F, Zhou Z, Gao C, Xiong J, et al: A novel rat model of chronic subdural hematoma: Induction of inflammation and angiogenesis in the subdural space mimicking human-like features of progressively expanding hematoma. Brain Res Bull. 172:108–119. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Wajima D, Nakagawa I, Nakase H and Yonezawa T: Neuroprotective effect of suppression of astrocytic activation by arundic acid on brain injuries in rats with acute subdural hematomas. Brain Res. 1519:127–135. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Asano T, Mori T, Shimoda T, Shinagawa R, Satoh S, Yada N, Katsumata S, Matsuda S, Kagamiishi Y and Tateishi N: Arundic acid (ONO-2506) ameliorates delayed ischemic brain damage by preventing astrocytic overproduction of S100B. Curr Drug Targets CNS Neurol Disord. 4:127–142. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Patabendige A, Singh A, Jenkins S, Sen J and Chen R: Astrocyte activation in neurovascular damage and repair following ischaemic stroke. Int J Mol Sci. 22(4280)2021.PubMed/NCBI View Article : Google Scholar | |
|
Bianchi R, Giambanco I and Donato R: S100B/RAGE-dependent activation of microglia via NF-kappaB and AP-1 Co-regulation of COX-2 expression by S100B, IL-1beta and TNF-alpha. Neurobiol Aging. 31:665–677. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Kumar M, Meode M, Blough M, Cairncross G and Bose P: PDGF gene expression and p53 alterations contribute to the biology of diffuse astrocytic gliomas. NPJ Genom Med. 8(6)2023.PubMed/NCBI View Article : Google Scholar | |
|
Shaw SS, Schmidt AM, Banes AK, Wang X, Stern DM and Marrero MB: S100B-RAGE-mediated augmentation of angiotensin II-induced activation of JAK2 in vascular smooth muscle cells is dependent on PLD2. Diabetes. 52:2381–2388. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Tyagi V, Theobald J, Barger J, Bustoros M, Bayin NS, Modrek AS, Kader M, Anderer EG, Donahue B, Fatterpekar G and Placantonakis DG: Traumatic brain injury and subsequent glioblastoma development: Review of the literature and case reports. Surg Neurol Int. 7(78)2016.PubMed/NCBI View Article : Google Scholar | |
|
Sirko S, Schichor C, Della Vecchia P, Metzger F, Sonsalla G, Simon T, Bürkle M, Kalpazidou S, Ninkovic J, Masserdotti G, et al: Injury-specific factors in the cerebrospinal fluid regulate astrocyte plasticity in the human brain. Nat Med. 29:3149–3161. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Michinaga S and Koyama Y: Pathophysiological responses and roles of astrocytes in traumatic brain injury. Int J Mol Sci. 22(6418)2021.PubMed/NCBI View Article : Google Scholar | |
|
Munch TN, Gørtz S, Wohlfahrt J and Melbye M: The long-term risk of malignant astrocytic tumors after structural brain injury-a nationwide cohort study. Neuro Oncol. 17:718–724. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Laird MD, Vender JR and Dhandapani KM: Opposing roles for reactive astrocytes following traumatic brain injury. Neurosignals. 16:154–164. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Huse JT and Holland EC: Targeting brain cancer: Advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer. 10:319–331. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Holl DC, Volovici V, Dirven C, Peul WC, van Kooten F, Jellema K, van der Gaag NA, Miah IP, Kho KH, den Hertog HM, et al: Pathophysiology and nonsurgical treatment of chronic subdural hematoma: From past to present to future. World Neurosurg. 116:402–411.e2. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Kim KH and Lee Y: Medical management of chronic subdural hematoma. Korean J Neurotrauma. 19:288–297. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Georgountzos G, Gkalonakis I, Anastasopoulos L, Stranjalis G and Kalamatianos T: Biofluid biomarkers in the prognosis of chronic subdural hematoma: A systematic scoping review. Diagnostics (Basel). 13(2449)2023.PubMed/NCBI View Article : Google Scholar | |
|
Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z and Hanahan D: Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol. 2:737–744. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Su GJ, Zhang D, Wu JN, Deng YH, Wu CW, Zhang XJ and Huang XJ: Immunoexpression of MMP-8 and MMP-9 in chronic subdural hematoma. Front Neurol. 13(988854)2022.PubMed/NCBI View Article : Google Scholar | |
|
Saleem M, Kweon MH, Johnson JJ, Adhami VM, Elcheva I, Khan N, Hafeez BB, Bhat KM, Sarfaraz S, Reagan-Shaw S, et al: S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Proc Natl Acad Sci USA. 103:14825–14830. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Zha C, Meng X, Li L, Mi S, Qian D, Li Z, Wu P, Hu S, Zhao S, Cai J and Liu Y: Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis. Cancer Biol Med. 17:154–168. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Wang M, Lv X, Wang Y, Li Y, Li H, Shen Z and Zhao L: Biomarkers of peripheral blood neutrophil extracellular traps in the diagnosis and progression of malignant tumors. Cancer Med. 13(e6935)2024.PubMed/NCBI View Article : Google Scholar | |
|
Nozawa H, Chiu C and Hanahan D: Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA. 103:12493–12498. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Zhang S, Guo M, Liu Q, Liu J and Cui Y: Neutrophil extracellular traps induce a hypercoagulable state in glioma. Immun Inflamm Dis. 9:1383–1393. 2021.PubMed/NCBI View Article : Google Scholar |
